Hyperhomocysteinemia as an independent risk factor for cardioembolic stroke in the Turkish population

Tohoku Journal of Experimental Medicine

Volumn 218, Issue 4, 2009, Pages 293-300

  Tascilar, Nida ^a   Ekem, Sureyya ^a   Aciman, Esra ^a   Ankarali, Handan ^b   Mungan, Gorkem ^b   Ozen, Banu ^a   Unal, Aysun ^a  

^a Department of Urology Faculty of Medicine Karaelmas University Zonguldak   (Turkey)

^b Zonguldak Karaelmas Universitesi Tip Fakultesi   (Turkey)

Author keywords

Atrial fibrillation; Homocysteine; Lipoprotein(a); Risk factors; Stroke

Indexed keywords

CYANOCOBALAMIN; CYSTEINE; FOLIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LIPID; LIPOPROTEIN A; METHIONINE;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; RISK ASSESSMENT; RISK FACTOR; STROKE; TURKEY (REPUBLIC); ATHEROSCLEROSIS; BLOOD; EMBOLISM; METABOLISM; METHODOLOGY; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; CHOLESTEROL, HDL; EMBOLISM; FEMALE; HUMANS; HYPERHOMOCYSTEINEMIA; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RISK FACTORS; STROKE; TURKEY;

EID: 70349757731     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.218.293     Document Type: Article

References (51)

1. Adams, H.P., Bendixen, B.H., Kappelle, L.J., Biller, J., Love, B.B., Gordon, D.L. & Marsh, E.E. 3rd. (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. Stroke, 24, 35-41.
2. Akaike, M., Azuma, H., Kagawa, A., Matsumoto, K., Hayashi, I., Tamura, K., Nishiuchi, T., Iuchi, T., Takamori, N., Aihara, K., Yoshida, T., Kanagawa, Y. & Matsumoto, T. (2002) Effect of aspirin treatment on serum concentrations of lipoprotein(a) in patients with atherosclerotic diseases. Clin. Chem., 48, 1454-1459.
3. Alfthan, G., Pekkanen, J., Jauhiainen, M., Pitkaniemi, J., Karvonen, M., Tuomilehto, J., Salonen, J.T. & Ehnholm, C. (1994) Relation of serum homocysteine and lipoprotein (a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis, 106, 9-19. (Pubitemid 24103795)
4. Ay, H., Arsava, E.M., Tokgozoglu, S.L., Ozer, N. & Saribas, O. (2003) Hyperhomocysteinemia is associated with the presence of left atrial thrombus in stroke patients with nonvalvular atrial fibrillation. Stroke, 34, 909-912. (Pubitemid 36402959)
5. Biller, J. & Love, B.B. (2004) Ischemic Cerebrovascular Disease. In Neurology in Clinical Practice, 4th ed., edited by W.G. Bradley, R.B. Daroff, C.M. Fenichel & J. Jankovic. Butterworth Heinemann, Philadelphia, PA, pp. 1197-1249.
6. Bots, M.L., Launer, L.J., Lindemans, J., Hoes, A.W., Hofman, A., Witteman, J.C.M., Koudstaal, P.J. & Grobbee, D.E. (1999) Homocysteine and short-term risk of myocardial infarction and stroke in the elderly: the Rotterdam study. Arch. Intern. Med., 159, 38-44.
7. Censori, B., Partziguian, T., Manara, O. & Poloni, M. (2007) Plasma homocysteine and severe white matter disease. Neurol. Sci., 28, 259-263.
8. Choy, P.C., Mymin, D., Zhu, Q., Dakshinamurti, K. & O, K. (2000) Atherosclerosis risk factors: the possible role of homocysteine. Mol. Cell. Biochem., 207, 143-148.
9. Cingozbay, B.Y., Yiginer, O., Cebeci, B.S., Kardesoglu, E., Demiralp, E. & Dincturk, M. (2002) Role of homocysteine for thromboembolic complication in patients with non-valvular atrial fibrillation. Blood Coagul. Fibrinolysis, 13, 609-613.
10. Dhamija, R.K., Gaba, P., Arora, S., Kaintura, A., Kumar, M. & Bhattacharjee, J. (2009) Homocysteine and lipoprotein (a) correlation in ischemic stroke patients. J. Neurol. Sci., 281, 64-68.
11. Eikelboom, J.W., Hankey, G.J., Anand, S.S., Lofthouse, E., Staples, N. & Baker, R.I. (2000) Association between high homocysteine and ischemic stroke due to large- and small-artery disease but not other etiologic subtypes of ischemic stroke. Stroke, 31, 1069-1075. (Pubitemid 30253527)
12. Evers, S., Koch, H.G., Grotemeyer, K.H., Lange, B., Deufel, T. & Ringelstein, E.B. (1997) Features, symptoms, and neurophysiological findings in stroke associated with hyperhomocysteinemia. Arch. Neurol., 54, 1276-1282.
13. Freyburger, C., Labrouche, S., Sassoust, C., Rouanet, F., Javorschi, S. & Parrot, F. (1997) Mild hyperhomocysteinemia and hemostatic factors in patients with arterial vascular diseases. Thromb. Haemost., 77, 466-471.
14. Friedman, H.S. (2001) Serum homocysteine and stroke in atrial fibrillation. Ann. Intern. Med., 134, 253-254.
15. Giles, W.H., Croft, J.B., Greenlund, K.J., Ford, E.S. & Kittner, S.J. (1998) Total homocysteine concentration and the likelihood of nonfatal stroke: results from the Third National Health and Nutrition Examination Survey, 1988-1994. Stroke, 29, 2473-2477.
16. Glueck, C.J., Shaw, P., Lang, J.E., Tracy, T., Smith, L.S. & Wang, Y. (1995) Evidence that homocysteine is an independent risk factor for atherosclerosis in hyperlipidemic patients. Am. J. Cardiol., 75, 132-136.
17. Graham, I.M., Daly, L.E., Refsum, H.M., Robinson, K., Brattstrom, L.E., Ueland, P.M., Palma-Reis, R.J., Boers, G.H., Sheahan, R.G., Israelsson, B., Uiterwaal, C.S., Meleady, R., McMaster, D., Verhoef, P., Witteman, J., Rubba, P., Bellet, H., Wautrecht, J.C., de Valk, H.W., Sales Lúis, A.C., Parrot-Rouland, F.M., Tan, K.S., Higgins, I., Garcon, D., & Andria, G., et al. (1997) Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA, 277, 1775-1781.
18. Hankey, G.J. & Eikelboom, J.W. (1999) Homocysteine and vascular disease. Lancet, 354, 407-413.
19. Hankey, G.J. & Warlow, C.P. (1999) Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations. Lancet, 354, 1457-1463.
20. Hart, R.G., Benavente, O., McBride, R. & Pearce, L.A. (1999) Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann. Intern. Med., 131, 492-501.
21. Kittner, S.J., Giles, W.H., Macko, R.F., Hebel, J.R., Wozniak, M.A., Wityk, R.J., Stolley, P.D., Stern, B.J., Sloan, M.A., Sherwin, R., Price, T.R., McCarter, R.J., Johnson, C.J., Earley C.J., Buchholz, D.W. & Malinow, M.R. (1999) Homocysteine and risk of cerebral infarction in a biracial population: the stroke prevention in young women study. Stroke, 30, 1554-1560. (Pubitemid 29379602)
22. Li, Z., Sun, L., Zhang, H., Liao, Y., Wang, D., Zhao, B., Zhu, Z., Zhao, J., Ma, A., Han, Y., Wang, Y., Shi, Y., Ye, J. & Hui, R.; Multicenter Case-Control Study in China. (2003) Elevated plasma homocysteine was associated with hemorrhagic and ischemic stroke, but methylenetetrahydrofolate reductase gene C677T polymorphism was a risk factor for thrombotic stroke. A multicenter case-control study in China. Stroke, 34, 2085-2090.
23. Loffredo, L., Violi, F., Fimognari, F.L., Cangemi, R., Sbrighi, P.S., Sampietro, F., Mazzola, G., Di Lecce, V.N. & D'Angelo, A. (2005) The association between hyperhomocysteinemia and ischemic stroke in patients with non-valvular atrial fibrillation. Haematologica, 90, 1205-1211. (Pubitemid 41375281)
24. Madonna, P., de Stefano, V., Coppola, A., Cirillo, F., Cerbone, A.M., Orefice, G. & Di Minno, G. (2002) Hyperhomocysteinemia and other inherited prothrombotic conditions in young adults with a history of ischemic stroke. Stroke, 33, 51-56. (Pubitemid 34052184)
25. Marcovina, S.M. & Koschinsky, M.L. (2003) Evaluation of lipoprotein(a) as a prothrombotic factor: progress from bench to bedside. Curr. Opin. Lipidol., 14, 361-366.
26. McCully, K.S. (1969) Vascular pathology of homocysteinemia: implications for the pathogenesis of atherosclerosis. Am. J. Pathol., 56, 111-128.
27. McQuillan, B.M., Beilby, J.P., Nidorf, M., Thompson, P.L. & Hung, J. (1999) Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS). Circulation, 99, 2383-2388.
28. Naruszewicz, M., Klinke, M., Dziewanowski, K., Staniewicz, A. & Bukowska, H. (2001) Homocysteine, fibrinogen, and lipoprotein(a) levels are simultaneously reduced in patients with chronic renal failure treated with folic acid, pyridoxine, and cyanocobalamin. Metabolism, 50, 131-134. (Pubitemid 32170822)
29. Ntaios, C.C., Savopoulos, C.G., Chatzinikolaou, A.C., Kaiafa, G.D. & Hatzitolios, A. (2008) Vitamins and stroke: the homocysteine hypothesis still in doubt. Neurologist, 14, 2-4.
30. Nygard, O., Refsum, H., Ueland, P.M. & Vollset, S.E. (1998) Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study. Am. J. Clin. Nutr., 67, 263-270.
31. O'Callaghan, P., Meleady, R., Fitzgerald, T. & Graham, I.; the European COMAC group. (2002) Smoking and plasma homocysteine. Eur. Heart. J., 23, 1580-1586.
32. Okubadejo, N.U., Oladipo, O.O., Adeyomoye, A.A., Awosanya, G.O. & Danesi, M.A. (2008) Exploratory study of total homocysteine and its relationship to short-term outcome in acute ischaemic stroke in Nigerians. BMC Neurol., 8, 26.
33. Perry, I.J., Refsum, H., Morris, R.W., Ebrahim, S.B., Ueland, P.M. & Shaper, A.G. (1995) Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet, 346, 1395-1398.
34. Pezzini, A., Grassi, M., Del Zotto, E., Assanelli, D., Archetti, S., Negrini, R., Caimi, L. & Padovani, A. (2006) Interaction of homocysteine and conventional predisposing factors on risk of ischaemic stroke in young people: consistency in phenotype-disease analysis and genotype-disease analysis. J. Neurol. Neurosurg. Psychiatry, 77, 1150-1156.
35. Piyathilake, C.J., Macaluso, M., Hine, R.J., Richards, E.W. & Krumdieck, C.L. (1994) Local and systemic effects of cigarette smoking on folate and vitamin B-12. Am. J. Clin. Nutr., 60, 559-566.
36. Poli, D., Antonucci, E., Cecchi, E., Marcucci, R., Liotta, A.A., Cellai, A.P., Lenti, M., Gensini, G.F., Abbate, R. & Prisco, D. (2005) Culprit factors for the failure of well-conducted warfarin therapy to prevent ischemic events in patients with atrial fibrillation: the role of homocysteine. Stroke, 36, 2159-2163. (Pubitemid 41429238)
37. Pulkkinen, A., Viitanen, L., Kareinen, A., Lehto, S. & Laakso, M. (2000) MspI polymorphism at +83 bp in intron 1 of the human apolipoprotein A1 gene is associated with elevated levels of HDL cholesterol and apolipoprotein A1 in nondiabetic subjects but not in type 2 diabetic patients with coronary heart disease. Diabetes Care, 23, 791-795. (Pubitemid 30414195)
38. Refsum, H., Nurk, E., Smith, A.D., Ueland, P.M., Gjesdal, C.C., Bjelland, I., Tverdal, A., Tell, G.S., Nygård, O. & Vollset, S.E. (2006) The Hordaland Homocysteine Study: a community-based study of homocysteine, its determinants, and association with disease. J. Nutr., 136, 1731S-1740S. (Pubitemid 43765389)
39. Refsum, H., Smith, A.D., Ueland, P.M., Nexo, E., Clarke, R., McPartlin, J., Johnston, C., Engbaek, F., Schneede, J., McPartlin, C. & Scott, J.M. (2004) Facts and recommendations about total homocysteine determinations: an expert opinion. Clin. Chem., 50, 3-32.
40. Refsum, H., Ueland, P.M., Nygard, O. & Vollset, S.E. (1998) Homocysteine and cardiovascular disease. Annu. Rev. Med., 49, 31-62.
41. Sacco, R.L., Anand, K., Lee, H.S., Boden-Albala, B., Stabler, S., Allen, R. & Paik, M.C. (2004) Homocysteine and the risk of ischemic stroke in a triethnic cohort: the Northern Manhattan Study. Stroke, 35, 2263-2269. (Pubitemid 39311247)
42. Shimizu, H., Kiyohara, Y., Kato, I., Tanizaki, Y., Ueno, H., Kimura, Y., Iwamoto, H., Kubo, M., Arima, H., Ibayashi, S. & Fujishima, M. (2002) Plasma homocysteine concentrations and the risk of subtypes of cerebral infarction. The Hisayama study. Cerebrovasc. Dis., 13, 9-15.
43. Spence, J.D. (2006) Nutrition and stroke prevention. Stroke, 37, 2430-2435.
44. Spence, J.D., Malinow, M.R., Barnett, P.A., Marian, A.J., Freeman, D. & Hegele, R.A. (1999) Plasma homocysteine concentration, but not MTHFR genotype, is associated with variation in carotid plaque area. Stroke, 30, 969-973. (Pubitemid 29211612)
45. Ueland, P.M., Refsum, H., Beresford, S.A.A. & Vollset, S.E. (2000) The controversy over homocysteine and cardiovascular risk. Am. J. Clin. Nutr., 72, 324-332.
46. Verhoef, P., Hennekens, C.H., Malinow, M.R., Kok, F.J., Willett, W.C. & Stampfer, M.J. (1994) A prospective study of plasma homocysteine and risk of ischemic stroke. Stroke, 25, 1924-1930. (Pubitemid 24291274)
47. Virtanen, J.K., Voutilainen, S., Alfthan, C., Korhonen, M.J., Rissanen, T.H., Mursu, J., Kaplan, G.A. & Salonen, J.T. (2005) Homocysteine as a risk factor for CVD mortality in men with other CVD risk factors: the Kuopio Ischaemic Heart Disease Risk Factor (KIHD) Study. J. Intern. Med., 257, 255-262.
48. Yokote, H., Shiraishi, A., Shintani, S. & Shiigai, T. (2007) Acute multiple brain infarction in large-artery atherosclerosis is associated with hyperhomocysteinemia. Acta Neurol. Scand., 116, 243-247.
49. Yoo, J.H., Chung, C.S. & Kang, S.S. (1998) Relation of plasma homocysteine to cerebral infarction and cerebral atherosclerosis. Stroke, 29, 2478-2483.
50. Youssef, M.Y., Mojiminiyi, O.A. & Abdella, N.A. (2007) Plasma concentrations of C-reactive protein and total homocysteine in relation to the severity and risk factors for cerebrovascular disease. Transl. Res., 150, 158-163.
51. Zhang, G. & Dai, C. (2001) Gene polymorphisms of homocysteine metabolism-related enzymes in Chinese patients with occlusive coronary artery or cerebral vascular diseases. Thromb. Res., 104, 187-195.